Rony Lenz-Alcayaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rony Lenz-Alcayaga has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Paredes-Fernández
Univ Nacl Andres Bello, Nucleo Acad Inst Salud Publ, Santiago, Chile
5 shared publications - Karla Hernández-Sánchez
Lenz Consultores
2 shared publications - Luciano Páez-Pizarro
Núcleo Académico Instituto de Salud Pública, Universidad Andrés Bello, Santiago, Chile
2 shared publications - Camila Rojas-Cáceres
Universidad de Chile
1 shared publication Daniela Paredes-Fernández
Public Health Institute, Universidad Andrés Bello, Santiago, Chile
1 shared publication- Diego Edwards
Clinica Alemana, Santiago, Region Metropolitana, Chile
1 shared publication
Latest Publications
- 3 September 2026
- Published by Medwave Estudios Limitada in Medwave
- Vol. 26 (08) , e3240
Impact of clean intermittent catheterization on quality of life and resource utilization in patients with spinal cord injury and urological complications: A narrative review
Objective To synthesize the international evidence on the impact of clean intermittent catheterization on quality of life and resource utilization in patients with spinal cord injury and urological complications, to support a review of policies that shift the financial burden of catheterization to families in Chile. Methods A narrative review based on the MEDLINE/PubMed database and gray literature published between 2014 and 2025, in Spanish and English. The research question was structured using the population, concept, and context framework. Two search algorithms were applied, combining MeSH terms, free-text keywords, and Boolean operators. Screening was conducted in three successive stages (title, abstract, and full text), with a second reviewer resolving any uncertainties by consensus. Results After screening 880 references, 65 studies met the inclusion criteria. Findings were organized into five dimensions: patient quality of life, caregiver quality of life, urinary tract infections, resource use, and emerging care models. Based on this evidence, an archetype of the chronic catheter user was developed: a man aged between 25 and 45 with a traumatic spinal cord injury, who uses a wheelchair in more than 67% of cases, spends more than 53 minutes a day on catheterization, has a prevalence of urinary tract infection exceeding 50% (two-thirds of which are antimicrobial resistant), and reports a 36% dissatisfaction with his urinary quality of life. Furthermore, he reuses catheters primarily for economic reasons; 90% of patients who used reusable catheters preferred switching to single-use catheters, and 84% reported greater satisfaction. Multiple cost-effectiveness analyses show that hydrophilic single-use catheters are cost-effective or dominant strategies in high-income settings. Caregivers -mostly mothers or partners- report insufficient training, social restriction, and work-related difficulties that the healthcare system fails to address. Conclusions Access to appropriate catheterization supplies, combined with structured patient and caregiver education and continuity of care, improves quality of life, reduces urinary complications, and is cost-effective. Chile’s current policy of shifting the financial burden of catheterization to families is inconsistent with the available international evidence.
- 3 September 2026
- Published by Medwave Estudios Limitada in Medwave
- Vol. 26 (08) , e3240
Impact of clean intermittent catheterization on quality of life and resource utilization in patients with spinal cord injury and urological complications: A narrative review
Objective To synthesize the international evidence on the impact of clean intermittent catheterization on quality of life and resource utilization in patients with spinal cord injury and urological complications, to support a review of policies that shift the financial burden of catheterization to families in Chile. Methods A narrative review based on the MEDLINE/PubMed database and gray literature published between 2014 and 2025, in Spanish and English. The research question was structured using the population, concept, and context framework. Two search algorithms were applied, combining MeSH terms, free-text keywords, and Boolean operators. Screening was conducted in three successive stages (title, abstract, and full text), with a second reviewer resolving any uncertainties by consensus. Results After screening 880 references, 65 studies met the inclusion criteria. Findings were organized into five dimensions: patient quality of life, caregiver quality of life, urinary tract infections, resource use, and emerging care models. Based on this evidence, an archetype of the chronic catheter user was developed: a man aged between 25 and 45 with a traumatic spinal cord injury, who uses a wheelchair in more than 67% of cases, spends more than 53 minutes a day on catheterization, has a prevalence of urinary tract infection exceeding 50% (two-thirds of which are antimicrobial resistant), and reports a 36% dissatisfaction with his urinary quality of life. Furthermore, he reuses catheters primarily for economic reasons; 90% of patients who used reusable catheters preferred switching to single-use catheters, and 84% reported greater satisfaction. Multiple cost-effectiveness analyses show that hydrophilic single-use catheters are cost-effective or dominant strategies in high-income settings. Caregivers -mostly mothers or partners- report insufficient training, social restriction, and work-related difficulties that the healthcare system fails to address. Conclusions Access to appropriate catheterization supplies, combined with structured patient and caregiver education and continuity of care, improves quality of life, reduces urinary complications, and is cost-effective. Chile’s current policy of shifting the financial burden of catheterization to families is inconsistent with the available international evidence.
- Open Access
- 2 March 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 27 (8) , 3375-3385
Budget impact analysis of neoadjuvant nivolumab for non-small cell lung cancer in the Chilean public healthcare system: An exploratory economic assessment
Purpose: Effective and sustainable treatments to improve patient outcomes are urgently needed for non-small cell lung carcinoma (NSCLC). Neoadjuvant therapies, particularly nivolumab, have shown superior outcomes in event-free survival and pathological response, yet financial coverage is scarce. We aim to provide an exploratory economic analysis to assess the implications of its incorporation into routine clinical practice. Methods: We conducted a six-step BIA (budget impact analysis) based on a decision tree model for pathways, probabilities, and resource utilization from the national payer perspective at an event-free survival (EFS) horizon. We estimated the direct cost of drugs and all healthcare-related services for two scenarios: a baseline scenario [neoadjuvant chemotherapy (CT)] and an alternative scenario [neoadjuvant nivolumab combined with chemotherapy (N + CT)]. Results: The funnel-down technique determined 359 eligible patients nationwide per year. The total cost of treatment in the baseline scenario amounts to CLP $ 7315 million Chilean pesos (€ 8,063,219) per cohort, with three top cost drivers: 1L drugs after recurrence (51.98%), resection (29.33%) and 2L nivolumab (5.85%). The alternative scenario amounted to CLP $ 6853 million (€ 7,553,572), with the highest relative expenditure attributed to the N + CT scheme (61.76%), resection (31.31%), and follow-up (2.73%). Adjuvant costs decrease to 1.03%, as does the expenditure on 1L (51.98% versus 0.34%) and 2L treatments (5.85% versus 0.18%). Early intervention in NSCLC reduces the budgetary impact by 6.3% (savings of − $ 462 million (€ 509,647) per treated cohort). Conclusions: Early incorporation of N + CT optimizes healthcare expenditure by providing access to therapies that improve survival rates while reducing the need for costly treatments in advanced stages. This approach represents a dominant strategy.- 2 March 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 27 (8) , 3375-3385
Open AccessBudget impact analysis of neoadjuvant nivolumab for non-small cell lung cancer in the Chilean public healthcare system: An exploratory economic assessment
Purpose: Effective and sustainable treatments to improve patient outcomes are urgently needed for non-small cell lung carcinoma (NSCLC). Neoadjuvant therapies, particularly nivolumab, have shown superior outcomes in event-free survival and pathological response, yet financial coverage is scarce. We aim to provide an exploratory economic analysis to assess the implications of its incorporation into routine clinical practice. Methods: We conducted a six-step BIA (budget impact analysis) based on a decision tree model for pathways, probabilities, and resource utilization from the national payer perspective at an event-free survival (EFS) horizon. We estimated the direct cost of drugs and all healthcare-related services for two scenarios: a baseline scenario [neoadjuvant chemotherapy (CT)] and an alternative scenario [neoadjuvant nivolumab combined with chemotherapy (N + CT)]. Results: The funnel-down technique determined 359 eligible patients nationwide per year. The total cost of treatment in the baseline scenario amounts to CLP $ 7315 million Chilean pesos (€ 8,063,219) per cohort, with three top cost drivers: 1L drugs after recurrence (51.98%), resection (29.33%) and 2L nivolumab (5.85%). The alternative scenario amounted to CLP $ 6853 million (€ 7,553,572), with the highest relative expenditure attributed to the N + CT scheme (61.76%), resection (31.31%), and follow-up (2.73%). Adjuvant costs decrease to 1.03%, as does the expenditure on 1L (51.98% versus 0.34%) and 2L treatments (5.85% versus 0.18%). Early intervention in NSCLC reduces the budgetary impact by 6.3% (savings of − $ 462 million (€ 509,647) per treated cohort). Conclusions: Early incorporation of N + CT optimizes healthcare expenditure by providing access to therapies that improve survival rates while reducing the need for costly treatments in advanced stages. This approach represents a dominant strategy. - Open Access
- 20 December 2024
- Published by Elsevier in Journal of Pathology Informatics
- Vol. 16, 100417
Economic evaluation: Impact on costs, time, and productivity of the incorporation of integrative digital pathology (IDP) in the anatomopathological analysis of breast cancer in a national reference public provider in Chile
- 20 December 2024
- Published by Elsevier in Journal of Pathology Informatics
- Vol. 16, 100417
Open AccessEconomic evaluation: Impact on costs, time, and productivity of the incorporation of integrative digital pathology (IDP) in the anatomopathological analysis of breast cancer in a national reference public provider in Chile
- 28 July 2023
- Published by Medwave Estudios Limitada in Medwave
- Vol. 23 (06) , e2682
Efficiency and productivity of the Chilean public health system between 2010 and 2019
Introduction In view of the strong increase in health expenditure, it is necessary to investigate whether proportional increases in healthcare production for the beneficiaries of the National Health Fund have corresponded to this increase. Methods In this observational, descriptive, and retrospective longitudinal research, we estimate the technical efficiency of the National Health Services System through the average cost of production and average labor productivity in the period from 2010 to 2019. Results During the studied decade, production has increased by approximately 6% annually; the number of workers increased (mostly physicians) by 61%; spending on salaries increased by 106% in real terms; spending on consumer goods and services has increased by 25% in real terms; the efficiency of spending has decreased by 21%, and productivity is the least dynamic element of the system with an average annual growth rate of 0.6%. After subtracting the diagnostic tests component, this scenario worsens. Conclusions The results show that higher health expenditure has not been matched by commensurate increases in output, translating into a fall in the efficiency of healthcare expenditure and meager increases or falls in productivity, depending on how the output is measured. This means that the public sector's growth strategy depends mainly on increases in the number of workers. This low productivity is a serious constraint to improving healthcare access for National Health Fund beneficiaries and contributes to increasing waiting lists. Special attention should be paid to average production costs and average labor productivity in a scenario of less dynamic growth in public health spending and health system reform.
- 28 July 2023
- Published by Medwave Estudios Limitada in Medwave
- Vol. 23 (06) , e2682
Efficiency and productivity of the Chilean public health system between 2010 and 2019
Introduction In view of the strong increase in health expenditure, it is necessary to investigate whether proportional increases in healthcare production for the beneficiaries of the National Health Fund have corresponded to this increase. Methods In this observational, descriptive, and retrospective longitudinal research, we estimate the technical efficiency of the National Health Services System through the average cost of production and average labor productivity in the period from 2010 to 2019. Results During the studied decade, production has increased by approximately 6% annually; the number of workers increased (mostly physicians) by 61%; spending on salaries increased by 106% in real terms; spending on consumer goods and services has increased by 25% in real terms; the efficiency of spending has decreased by 21%, and productivity is the least dynamic element of the system with an average annual growth rate of 0.6%. After subtracting the diagnostic tests component, this scenario worsens. Conclusions The results show that higher health expenditure has not been matched by commensurate increases in output, translating into a fall in the efficiency of healthcare expenditure and meager increases or falls in productivity, depending on how the output is measured. This means that the public sector's growth strategy depends mainly on increases in the number of workers. This low productivity is a serious constraint to improving healthcare access for National Health Fund beneficiaries and contributes to increasing waiting lists. Special attention should be paid to average production costs and average labor productivity in a scenario of less dynamic growth in public health spending and health system reform.
- Open Access
- 29 November 2021
- Published by Medwave Estudios Limitada in Medwave
- Vol. 21 (10) , e8490
Women’s access to health care: Gaps that the future health care reform in Chile must solve
Introduction In the Chilean health system, difficulties complicate women’s access to health care and aggravate the complexity of health-illness processes in their interaction as users or caregivers. Objective In the national and international literature, we aimed to identify gaps in women’s access to health care derived from gender disparities and the exercise of gender roles in a prioritized set of health problems. These problems exacerbate gender gaps and should be considered in health reform. Methods We made a literature review through algorithms, snowball sampling, and reference lists from November 2020 to March 2021. The population included were women of all ages, including women users of the health system and women caregivers of specific pathologies. The search was conducted in parallel by four investigators divided into two groups. It was cross-validated to ensure inter-investigator reliability by standardizing evidence eligibility criteria. The analysis showed women users' and caregivers' dimensions for a set of pathologies prioritized by the extent of the disease burden. The pathologies analyzed included stroke, obesity, depression, musculoskeletal pain, and breast cancer. Results Among women users of the health system, problems of access, rates of use, experience, and outcome for the whole group of prioritized pathologies were observed. In the women caregiver dimension, we found that women are the primary health care providers. There is a knowledge gap concerning obesity and musculoskeletal conditions. However, both were reported as health consequences of women’s caregiving roles.
- 29 November 2021
- Published by Medwave Estudios Limitada in Medwave
- Vol. 21 (10) , e8490
Open AccessWomen’s access to health care: Gaps that the future health care reform in Chile must solve
Introduction In the Chilean health system, difficulties complicate women’s access to health care and aggravate the complexity of health-illness processes in their interaction as users or caregivers. Objective In the national and international literature, we aimed to identify gaps in women’s access to health care derived from gender disparities and the exercise of gender roles in a prioritized set of health problems. These problems exacerbate gender gaps and should be considered in health reform. Methods We made a literature review through algorithms, snowball sampling, and reference lists from November 2020 to March 2021. The population included were women of all ages, including women users of the health system and women caregivers of specific pathologies. The search was conducted in parallel by four investigators divided into two groups. It was cross-validated to ensure inter-investigator reliability by standardizing evidence eligibility criteria. The analysis showed women users' and caregivers' dimensions for a set of pathologies prioritized by the extent of the disease burden. The pathologies analyzed included stroke, obesity, depression, musculoskeletal pain, and breast cancer. Results Among women users of the health system, problems of access, rates of use, experience, and outcome for the whole group of prioritized pathologies were observed. In the women caregiver dimension, we found that women are the primary health care providers. There is a knowledge gap concerning obesity and musculoskeletal conditions. However, both were reported as health consequences of women’s caregiving roles.
- 30 April 2021
- Published by Medwave Estudios Limitada in Medwave
- Vol. 21 (03) , e8152
Cost-utility analysis: Mechanical thrombectomy plus thrombolysis in ischemic stroke due to large vessel occlusion in the public sector in Chile
Introduction Several studies demonstrate the therapeutic superiority of thrombolysis plus mechanical thrombectomy versus thrombolysis alone to treat stroke. Objective To analyze the cost-utility of thrombolysis plus mechanical thrombectomy versus thrombolysis in patients with ischemic stroke due to large vessel occlusion. Methods Cost-utility analysis. The model used is blended: Decision Tree (first 90 days) and Markov in the long term, of seven health states based on a disease-specific scale, from the Chilean public insurance and societal perspective. Quality-Adjusted Life-Years and costs are evaluated. Deterministic (DSA) and probabilistic (PSA) analyses were carried out. Results From the public insurance perspective, in the base case, mechanical thrombectomy is associated with lower costs in a lifetime horizon, and with higher benefits (2.63 incremental QALYs, and 1.19 discounted incremental life years), at a Net Monetary Benefit (NMB) of CLP 37,289,874, and an Incremental Cost-Utility Ratio (ICUR) of CLP 3,807,413/QALY. For the scenario that incorporates access to rehabilitation, 2.54 incremental QALYs and 1.13 discounted life years were estimated, resulting in an NMB of CLP 35,670,319 and ICUR of CLP 3,960,624/QALY. In the scenario that incorporates access to long-term care from a societal perspective, the ICUR falls to CLP 951,911/QALY, and the NMB raises to CLP 43,318,072, improving the previous scenarios. In the DSA, health states, starting age, and relative risk of dying were the variables with the greatest influence. The PSA for the base case corroborated the estimates. Conclusions Thrombolysis plus mechanical thrombectomy adds quality of life at costs acceptable for decision-makers versus thrombolysis alone. The results are consistent with international studies.
- 30 April 2021
- Published by Medwave Estudios Limitada in Medwave
- Vol. 21 (03) , e8152
Cost-utility analysis: Mechanical thrombectomy plus thrombolysis in ischemic stroke due to large vessel occlusion in the public sector in Chile
Introduction Several studies demonstrate the therapeutic superiority of thrombolysis plus mechanical thrombectomy versus thrombolysis alone to treat stroke. Objective To analyze the cost-utility of thrombolysis plus mechanical thrombectomy versus thrombolysis in patients with ischemic stroke due to large vessel occlusion. Methods Cost-utility analysis. The model used is blended: Decision Tree (first 90 days) and Markov in the long term, of seven health states based on a disease-specific scale, from the Chilean public insurance and societal perspective. Quality-Adjusted Life-Years and costs are evaluated. Deterministic (DSA) and probabilistic (PSA) analyses were carried out. Results From the public insurance perspective, in the base case, mechanical thrombectomy is associated with lower costs in a lifetime horizon, and with higher benefits (2.63 incremental QALYs, and 1.19 discounted incremental life years), at a Net Monetary Benefit (NMB) of CLP 37,289,874, and an Incremental Cost-Utility Ratio (ICUR) of CLP 3,807,413/QALY. For the scenario that incorporates access to rehabilitation, 2.54 incremental QALYs and 1.13 discounted life years were estimated, resulting in an NMB of CLP 35,670,319 and ICUR of CLP 3,960,624/QALY. In the scenario that incorporates access to long-term care from a societal perspective, the ICUR falls to CLP 951,911/QALY, and the NMB raises to CLP 43,318,072, improving the previous scenarios. In the DSA, health states, starting age, and relative risk of dying were the variables with the greatest influence. The PSA for the base case corroborated the estimates. Conclusions Thrombolysis plus mechanical thrombectomy adds quality of life at costs acceptable for decision-makers versus thrombolysis alone. The results are consistent with international studies.
- Open Access
- 28 February 2021
- Published by Medwave Estudios Limitada in Medwave
- Vol. 21 (01) , e8117
Evolution of health social security expenditure in Chile: A review of financial aggregates from 2000 to 2018
Introduction In Chile, there is controversy regarding the magnitude of financing for the health system. Some experts state that more resources are needed, while others refer to the problems that may arise in managing a growing pool of resources. Aim This article aims to offer evidence to encourage critical discussion through a time series analysis of the leading financial aggregates in constant 2018 Chilean pesos of the Chilean social security in the period from 2000 to 2018. Methods We did an observational, descriptive, longitudinal, and time series trend analysis study. Financial aggregates are organized according to social security definitions and by financial administrators—the public National Health Fund and the private health insurers. Results Social security health spending has increased almost four-fold in the study period. After enacting the Explicit Guarantees in Health, the National Health Fund expanded more than the private health insurance system due to government allocations to the National Health Fund. In contrast, individual contributions decreased steadily every year during the study period. Per capita expenditure was higher in the private health insurance system. However, the per capita expenditure of the private insurance system over the public health fund has gradually decreased over time. Conclusion Firstly, Chile increased its health spending at a rate higher than observed in other Organization for Economic Co-operation and Development countries. Secondly, it transitioned from financing health mainly through workers’ contributions to growing prominence of the government’s overall contribution. In the wake of the announced health reform, the discussion of health funding will include employers’ role in health financing.
- 28 February 2021
- Published by Medwave Estudios Limitada in Medwave
- Vol. 21 (01) , e8117
Open AccessEvolution of health social security expenditure in Chile: A review of financial aggregates from 2000 to 2018
Introduction In Chile, there is controversy regarding the magnitude of financing for the health system. Some experts state that more resources are needed, while others refer to the problems that may arise in managing a growing pool of resources. Aim This article aims to offer evidence to encourage critical discussion through a time series analysis of the leading financial aggregates in constant 2018 Chilean pesos of the Chilean social security in the period from 2000 to 2018. Methods We did an observational, descriptive, longitudinal, and time series trend analysis study. Financial aggregates are organized according to social security definitions and by financial administrators—the public National Health Fund and the private health insurers. Results Social security health spending has increased almost four-fold in the study period. After enacting the Explicit Guarantees in Health, the National Health Fund expanded more than the private health insurance system due to government allocations to the National Health Fund. In contrast, individual contributions decreased steadily every year during the study period. Per capita expenditure was higher in the private health insurance system. However, the per capita expenditure of the private insurance system over the public health fund has gradually decreased over time. Conclusion Firstly, Chile increased its health spending at a rate higher than observed in other Organization for Economic Co-operation and Development countries. Secondly, it transitioned from financing health mainly through workers’ contributions to growing prominence of the government’s overall contribution. In the wake of the announced health reform, the discussion of health funding will include employers’ role in health financing.
- Open Access
- 25 December 2020
- Published by Medwave Estudios Limitada in Medwave
- Vol. 20 (11) , e8086
Economic evaluation in health: Cost-utility of the incorporation of total knee replacement to the Chilean Explicit Health-Guarantees regime
Osteoarthritis is an important health condition due to its prevalence and functional deterioration, being the most common cause of disability in people over 65 years of age. The Chilean Explicit Health-Guarantees regime provides coverage for medical treatment in mild and moderate presentations, excluding surgical treatment in end-stage knee osteoarthritis. To evaluate the cost-utility of incorporating total knee replacement to the Explicit Health-Guarantees regime for over-65-years beneficiaries of the public insurance system, versus maintenance with medical treatment. A Scoping review was coducted to identify model parameters and economic evaluation based in a 6 health states Markov Model, from the perspective of the public payer and lifetime horizon. The Incremental Cost-Utility Ratio (ICUR) was calculated, and deterministic and probabilistic uncertainty analysis were performed. Twenty-two articles were selected as reference sources. If the regime were to adopt the procedure, the implication would be a benefit of 9.8 Years of Life Adjusted by Quality (QALY) versus 2.4 QALY in the scenario without access to total knee replacement. The ICUR was $ -445 689 CLP/QALY (U$D -633.8/QALY), wherein the inclusion of total knee replacement to the regime becomes a dominant alternative versus the current scenario. Each quality-adjusted life-year gained by the surgery will save CLP 445 689. At a willingness to pay of CLP 502,596/QALY (U$D 714.7/QALY), access to surgery is cost-useful with a 99.9% certainty. Total knee replacement in patients older than 65 years is a dominant alternative. Access to this procedure in the Chilean Explicit Health-Guarantees regime in the public system is cost-useful at a threshold of 1 GDP per capita.
- 25 December 2020
- Published by Medwave Estudios Limitada in Medwave
- Vol. 20 (11) , e8086
Open AccessEconomic evaluation in health: Cost-utility of the incorporation of total knee replacement to the Chilean Explicit Health-Guarantees regime
Osteoarthritis is an important health condition due to its prevalence and functional deterioration, being the most common cause of disability in people over 65 years of age. The Chilean Explicit Health-Guarantees regime provides coverage for medical treatment in mild and moderate presentations, excluding surgical treatment in end-stage knee osteoarthritis. To evaluate the cost-utility of incorporating total knee replacement to the Explicit Health-Guarantees regime for over-65-years beneficiaries of the public insurance system, versus maintenance with medical treatment. A Scoping review was coducted to identify model parameters and economic evaluation based in a 6 health states Markov Model, from the perspective of the public payer and lifetime horizon. The Incremental Cost-Utility Ratio (ICUR) was calculated, and deterministic and probabilistic uncertainty analysis were performed. Twenty-two articles were selected as reference sources. If the regime were to adopt the procedure, the implication would be a benefit of 9.8 Years of Life Adjusted by Quality (QALY) versus 2.4 QALY in the scenario without access to total knee replacement. The ICUR was $ -445 689 CLP/QALY (U$D -633.8/QALY), wherein the inclusion of total knee replacement to the regime becomes a dominant alternative versus the current scenario. Each quality-adjusted life-year gained by the surgery will save CLP 445 689. At a willingness to pay of CLP 502,596/QALY (U$D 714.7/QALY), access to surgery is cost-useful with a 99.9% certainty. Total knee replacement in patients older than 65 years is a dominant alternative. Access to this procedure in the Chilean Explicit Health-Guarantees regime in the public system is cost-useful at a threshold of 1 GDP per capita.
- Open Access
- 31 October 2020
- Published by Medwave Estudios Limitada in Medwave
- Vol. 20 (09) , e8041
Characterization and analysis of the basic elements of health payment mechanisms and their most frequent types
Introduction Healthcare systems are developed in imperfect scenarios, in which there are constant failures (uncertainty, information asymmetry, agency relationship problem, and supply-induced demand). These failures, based on the imperfection of the sector, determine the relationships and incentives between the actors. It is within this context that payment mechanisms regulate aspects of the system behavior and incentives, acting as instruments for the purchasing of health care from providers, mediated by health insurance on behalf of users. Objective To characterize the basic elements of most frequent payment mechanisms to help providers in their relationship with payers. Methods A review of the evidence was conducted in PubMed, Google, Google Scholar, and strategic snowball selection. Payment mechanisms consist of three classical microeconomics variables, fixed or variable: price, quantity, and expense. Time dimensions are used to analyze their attributes and effects. Different mechanisms emerge from the combination of these variables. Results Among the most used are: Fee-For-Service, Global Budget, Bundled Payments, Diagnosis-Related Groups, Per-capita, Performance Pay, and Risk-Sharing Agreements. A fourth has also gained importance: Financial Risk. Conclusions Payment mechanisms are essential to link health efforts with clinical practice. They make it possible to regulate relationships between insurers, providers, and users, which, depending on the architecture of the mechanism, can become beneficial or hinder the fulfillment of the objectives of the health system.
- 31 October 2020
- Published by Medwave Estudios Limitada in Medwave
- Vol. 20 (09) , e8041
Open AccessCharacterization and analysis of the basic elements of health payment mechanisms and their most frequent types
Introduction Healthcare systems are developed in imperfect scenarios, in which there are constant failures (uncertainty, information asymmetry, agency relationship problem, and supply-induced demand). These failures, based on the imperfection of the sector, determine the relationships and incentives between the actors. It is within this context that payment mechanisms regulate aspects of the system behavior and incentives, acting as instruments for the purchasing of health care from providers, mediated by health insurance on behalf of users. Objective To characterize the basic elements of most frequent payment mechanisms to help providers in their relationship with payers. Methods A review of the evidence was conducted in PubMed, Google, Google Scholar, and strategic snowball selection. Payment mechanisms consist of three classical microeconomics variables, fixed or variable: price, quantity, and expense. Time dimensions are used to analyze their attributes and effects. Different mechanisms emerge from the combination of these variables. Results Among the most used are: Fee-For-Service, Global Budget, Bundled Payments, Diagnosis-Related Groups, Per-capita, Performance Pay, and Risk-Sharing Agreements. A fourth has also gained importance: Financial Risk. Conclusions Payment mechanisms are essential to link health efforts with clinical practice. They make it possible to regulate relationships between insurers, providers, and users, which, depending on the architecture of the mechanism, can become beneficial or hinder the fulfillment of the objectives of the health system.